0001567619-19-015049.txt : 20190719 0001567619-19-015049.hdr.sgml : 20190719 20190719213635 ACCESSION NUMBER: 0001567619-19-015049 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190717 FILED AS OF DATE: 20190719 DATE AS OF CHANGE: 20190719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boucher Brent J. CENTRAL INDEX KEY: 0001766229 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50761 FILM NUMBER: 19964401 MAIL ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIODYNAMICS INC CENTRAL INDEX KEY: 0001275187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 113146460 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 BUSINESS PHONE: 5187981215 MAIL ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 4 1 doc1.xml FORM 4 X0306 4 2019-07-17 0 0001275187 ANGIODYNAMICS INC ANGO 0001766229 Boucher Brent J. 14 PLAZA DRIVE LATHAM NY 12110 0 1 0 0 SVP and GM of Oncology Common Stock 2019-07-17 4 A 0 3226 0 A 16769 D Non-Qualified Stock Option (right to buy) 21.54 2019-07-17 4 A 0 10790 0 A 2020-07-17 2029-07-17 Common Stock 10790 10790 D This acquisition of 3,226 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 3,226 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal installments beginning on July 17, 2020, such that 25% of the restricted stock units will vest on each of July 17, 2020, 2021, 2022 and 2023. These stock options vest in four equal annual installments beginning on July 17, 2020, such that 25% of the options will vest on each of July 17, 2020, 2021, 2022 and 2023. /s/ Stephen A. Trowbridge, Attorney in Fact 2019-07-19